Business
Pulse Biosciences Schedules Third Quarter 2021 Financial Results Conference Call for November 15, 2021
HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™)
About this update from Pulse Biosciences, Inc
[{"type":"text","content":" HAYWARD, Calif.--(BUSINESS WIRE)--\nPulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™) technology, announced today it will report financial results for the third quarter of 2021 after market close on Monday, November 15, 2021. Company management will host a corresponding conference call beginning at 1:30pm PT.\n\nInvestors interested in listening to the conference call may do so by dialing 1-877-705-6003 for domestic callers or 1-201-493-6725 for international callers. A live and recorded webcast of the event will be available at http://investors.pulsebiosciences.com/.\n\nAbout Pulse Biosciences®\n\nPulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients. The CellFX® System is the first commercial product to harness the distinctive advantages of the Company’s proprietary Nano-Pulse Stimulation™ (NPS™) technology, such as the ability to non-thermally clear cells while sparing non-cellular tissue, to treat a variety of applications for which an optimal solution remains unfulfilled. Nano-Pulse Stimulation technology delivers nano-second pulses of electrical energy. The initial commercial use of the CellFX System is to address a range of dermatologic conditions that share high demand among patients and practitioners for improved dermatologic outcomes. Designed as a multi-application platform, the CellFX System offers customer value with a utilization-based revenue model. To learn more, please visit pulsebiosciences.com.\n\nTo stay informed about the CellFX System, please visit CellFX.com and sign up for updates.\n\nPulse Biosciences, CellFX, Nano-Pulse Stimulation, NPS and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United States and other countries.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20211102006258/en/\n\nInvestors:\nPulse Biosciences\nSandra Gardiner, EVP and CFO\n510.241.1077\[email protected]\nor\nGilmartin Group\nPhilip Trip Taylor\n415.937.5406\[email protected]\n\nMedia:\nTosk Communications\nNadine D. Tosk\n504.453.8344\[email protected]\n\nSource: Pulse Biosciences, Inc.","length":4283,"tagName":"div"}]